>12 Bewernick B. H. et al. Nucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression // Biological Psychiatry. 15 January 2010. Vol. 67. No. 2. P. 110–116.
>13 Diana M. The Dopamine Hypothesis of Drug Addiction and Its Potential Therapeutic Value // Front Psychiatry. 2011. Vol. 2. P. 64.
>14 Griesar W. S. et al. Nicotine Effects on Alertness and Spatial Attention in Non-Smokers // Nicotine & Tobacco Research. May 2002. Vol. 4. No. 2. Р. 185–194.
>15 Shah D. et al. Neural Effects of Acute Nicotinic Treatment on Visual Spatial Attention in Non-Smokers // Pharmacology, Biochemistry and Behavior. 2011. Vol. 100. P. 228–236.
>16 Govind A. P. et al. Nicotine-Induced Upregulation of Nicotinic Receptors: Underlying Mechanisms and Relevance to Nicotine Addiction // Biochemical Pharmacology. 2009. Vol. 78. P. 756–765.
>17 Ware J. J. et al. From Men to Mice: CHRNA5/CHRNA3, Smoking Behavior and Disease // Nicotine &Tobacco Research. 2012.
>18 Kaur-Knudsen D. et al. CHRNA3 Genotype, Nicotine Dependence, Lung Function and Disease in the General Population // European Respiratory Journal. 2012. Vol. 40.
P. 1538–1544.
>19 Bierut L. J. et al. Variants in Nicotinic Receptors and Risk for Nicotine Dependence // The American Journal of Psychiatry. 2008. Vol. 165. P. 1163–1171.
>20 Sherva R. et al. Association of a Single Nucleotide Polymorphism in Neuronal Acetylcholine Receptor Subunit Alpha 5 (CHRNA5) with Smoking Status and with ‘Pleasurable Buzz’ During Early Experimentation with Smoking // Addiction. September 2008. Vol. 103. No. 9. P. 1544–1552.
>21 Janes A. C. et al. Association between CHRNA5 Genetic Variation at Rs16969968 and Brain Reactivity to Smoking Images in Nicotine Dependent Women // Drug and Alcohol Dependence. 1 January 2012. Vol. 120. No. 1–3. P. 7–13.
>22 Li M. D. The Genetics of Nicotine Dependence // Current Psychiatry Reports. 2006. Vol. 8. P. 158–164.
>23http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5114a2.htm — оценка опасности курения от Министерства здравоохранения США.
>24 Bornman M. S., du Plessis D. J. Smoking and Vascular Impotence. A Reason for Concern // South African Medical Journal. 13 September 1986. Vol. 70. No. 6. P. 329–30.
>25 Mamede M. et al.Temporal Change in Human Nicotinic Acetylcholine Receptor After Smoking Cessation: 5IA SPECT Study // Journal of Nuclear Medicine. 2007. Vol. 48. P. 1829–1835.
>26 Taylor D. H. et al. Benefits of Smoking Cessation for Longevity // The American Journal of Public Health. June 2002. Vol. 92. No. 6. P. 990–996.